Phaseline

Targets › GR

GR: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Respiratory; next expected readout Apr 2028.

Open in Phaseline: the race on GR, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of MiamiAlbuterol-Budesonide (AIRSUPRA)
Fast-acting beta-2 agonist and inhaled corticosteroid combination
ADRB2, GRPhase 4AsthmaApr 2028

Conditions

Asthma (1)

Modalities

small molecule (1)

Companies

University of Miami (1)

Related targets

ADRB2 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.